This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Curnutte, M.A., Frumovitz, K.L., Bollinger, J.M., McGuire, A.L. & Kaufman, D.J. Nat. Biotechnol. 32, 980–982 (2014).
Ratner, M. Nat. Biotechnol. 31, 663–665 (2013).
Weldon, C.B., Trosman, J.R., Gradishar, W.J., Benson, A.B. III & Schink, J.C. J. Oncol. Pract. 8, e24–31 (2012).
Trosman, J.R., Van Bebber, S.L. & Phillips, K.A. J. Oncol. Pract. 7, 18s–24s (2011).
Daly, M. et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Genetic/Familial High-Risk Assessment: Breast and Ovarian (version 2.2105). http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. (2015). Accessed July 19, 2015.
Graf, M.D., Needham, D.F., Teed, N. & Brown, T. Per. Med. 10, 235–243 (2013).
Wang, G., Beattie, M.S., Ponce, N.A. & Phillips, K.A. Genet. Med. 13, 1045–1050 (2011).
Heger, M. Official Discusses Wash U's Successful Strategy in Developing a Reimbursable NGS Cancer Test. http://www.genomeweb.com/sequencing/official-discusses-wash-us-successful-strategy-developing-reimbursable-ngs-cance. (2014). Accessed June 30, 2014.
Trosman, J.R., Weldon, C.B., Kelley, R.K. & Phillips, K.A. J. Natl. Compr. Canc. Netw. 13, 311–318 (2015).
Kurian, A.W. et al. J. Clin. Oncol. 32, 2001–2009 (2014).
Domchek, S.M., Bradbury, A., Garber, J.E., Offit, K. & Robson, M.E. J. Clin. Oncol. 31, 1267–1270 (2013).
Kurian, A.W., Kingham, K.E. & Ford, J.M. Curr. Opin. Obstet. Gynecol. 27, 23–33 (2015).
Turnbull, C. & Rahman, N. Annu. Rev. Genomics Hum. Genet. 9, 321–345 (2008).
Couch, F.J., Nathanson, K.L. & Offit, K. Science (New York, N.Y.) 343, 1466–1470 (2014).
Hiraki, S., Rinella, E.S., Schnabel, F., Oratz, R. & Ostrer, H. J. Genet. Couns. 23, 604–617 (2014)
This study was partially funded by a National Human Genome Research Institute grant to K.A.P. (R01HG007063), a National Cancer Institute grant to the University of California at San Francisco (UCSF), Helen Diller Family Comprehensive Cancer Center (5P30CA082013-15) and the UCSF Mount Zion Health Fund. E.C. received Summer Research Fellowship funds from the Albert Einstein College of Medicine in support of this study.
K.A.P. has received honoraria for speaking at a professional conference session sponsored by Invitae. Disclosures have been reviewed by the University of California, San Francisco. J.T. and C.W. both received funding from an unrestricted grant from Myriad Genetics.
About this article
Cite this article
Clain, E., Trosman, J., Douglas, M. et al. Availability and payer coverage of BRCA1/2 tests and gene panels. Nat Biotechnol 33, 900–902 (2015). https://doi.org/10.1038/nbt.3322
Familial Cancer (2022)
Nature Reviews Clinical Oncology (2021)
A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries
Oncology and Therapy (2021)
Current Genetic Medicine Reports (2019)
Nature Biotechnology (2017)